William Rose
Chairman at Greenhill School
Profile
William Edward Rose is currently the Chairman at Greenhill School.
He previously worked as a Managing Director at HBK Investments LP, a Director at Impac Mortgage Holdings, Inc., and as the President of Montrose Capital, Inc. He also served as an Independent Director at Reata Pharmaceuticals, Inc. from 2016 to 2023.
Mr. Rose received his undergraduate degree from Duke University in 1989.
William Rose active positions
| Companies | Position | Start |
|---|---|---|
| Greenhill School | Chairman | - |
Former positions of William Rose
| Companies | Position | End |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Director/Board Member | 2023-09-25 |
| Montrose Capital, Inc. | President | - |
HBK Investments LP
 HBK Investments LP Investment ManagersFinance HBK Investments LP, do-business-as HBK Capital Management (HBK), is a SEC-registered investment advisor and hedge fund manager headquartered in Dallas, Texas. The firm was founded in 1991 and is a subsidiary of HBK Partners II LP. HBK provides discretionary investment management services and related administrative services to their funds, which are private investment funds offered only to sophisticated investors with substantial resources. | Chief Investment Officer | - |
| IMPAC MORTGAGE HOLDINGS, INC. | Director/Board Member | - |
Training of William Rose
| Duke University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IMPAC MORTGAGE HOLDINGS, INC. | Finance |
| Private companies | 3 |
|---|---|
HBK Investments LP
HBK Investments LP Investment ManagersFinance HBK Investments LP, do-business-as HBK Capital Management (HBK), is a SEC-registered investment advisor and hedge fund manager headquartered in Dallas, Texas. The firm was founded in 1991 and is a subsidiary of HBK Partners II LP. HBK provides discretionary investment management services and related administrative services to their funds, which are private investment funds offered only to sophisticated investors with substantial resources. | Finance |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
| Montrose Capital, Inc. |
- Stock Market
- Insiders
- William Rose
